— Sarah Korman, chief legal officer at Vancouver, Wash.-based biotech company Absci, will depart Sept. 15, according to a regulatory filing. The company, which is developing technologies to accelerate the… Read More
Cajal Neuroscience, a Seattle startup taking a unique approach to developing treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s, revealed more details about its strategy and announced $96 million in… Read More